Skip to content
Cold-chain shipping · Ships from Canada · Research use only
Metabolic

Tesamorelin Peptide in Canada

Tesamorelin is a stabilised 44 amino acid version of GHRH, the brain's growth hormone signal. Montreal's Theratechnologies developed it, and the FDA approved it as Egrifta in 2010 after two Phase 3 trials. That approval covers one prescription use: excess abdominal fat in people with HIV. It's no longer marketed in Canada, and Europe never approved it.

Tesamorelin peptide 10mg vial, Pro Peptide
$54.77CAD per vial

Pack prices and discount codes don't combine. You always get the bigger saving.

1

In stock · ships same-day with ice pack

Sold for laboratory research use only. Not for human or veterinary use. 19+.

Amino acids, capped to resist breakdown
44
Molar mass
5135.83g/mol
FDA approval, as Egrifta
2010
Phase 3 trials, both in people with HIV
2
Canadian product listing cancelled
2022

What is Tesamorelin?

The plain-language version, first.

Forty-four residues, a full development programme, and a Canadian postcode.

Here's a number that should bother you.

Of everything on this shelf, the count that ran a full development programme, survived every phase, and came out the other side with a regulator's signature is basically one.

This is it. And it came out of Montreal.

Tesamorelin is a 44-residue analogue of GHRH, which is the hormone your hypothalamus sends to tell your pituitary to release growth hormone. Native GHRH is a fragile thing. DPP-4 finds it and cuts it inside minutes.

So the modification is a stabilising group on the N-terminus that stops the enzyme getting a grip.

Theratechnologies took it the whole way and the FDA approved it in 2010, for a specific condition in a specific patient population, under prescription and supervision.

None of which describes what is in this vial, or who is buying it. That approval belongs to a supervised medicine, not to research powder ordered online.

What is tesamorelin?

What researchers watch it do.

It doesn't do the job itself. It asks the pituitary to do the job.

Look, there are two ways to raise a signal in a system like this.

You can flood it from outside, or you can go upstream and ask the thing that already makes it to make a bit more.

This is the second kind. It's a message to the pituitary, not a replacement for what the pituitary sends.

That distinction matters more than it sounds. An upstream nudge still runs through the body's own feedback loops, which means the system keeps some say in the outcome.

The engineering problem was never getting GHRH to work. Your body proves it works several times a day. The problem was that GHRH is disposable by design and clears in minutes.

Here's the honest part. Everything above is mechanism, and mechanism is the easy half.

What it produces in a person was studied properly, under supervision, in a population selected for a trial. That is not the same as what happens to anybody who buys powder.

What does the research say about Tesamorelin?

What the studies found, and where they stand.

The rarest thing in this catalogue: a peptide that made it all the way through.

This one has a real file, and it is worth being precise about what kind of file it is.

A full development programme, phase 1 through 3, a regulatory submission, and an approval granted in 2010.

Which puts it in a category almost nothing else here belongs to.

But read the approval carefully, because vendors love to quote the existence of it and skip the shape of it.

It was granted for one narrow indication, in one specific patient group, as a prescription product with medical oversight. The label is unusually explicit about what it is not approved for, and that sentence exists because people were always going to try.

An approval is a permission granted to a particular product for a particular use. It is not a general endorsement of a molecule, and anybody selling it as one is misreading the document on purpose.

Have a look at current stock and vial sizes.

What did the lab find in our Tesamorelin?

3 sizes, one lot each, the lab's numbers for every one.

5 mgLot 2280-65098.9%5.08 mgOpen
98.9%HPLC purity
Lot 2280-650
LaboratoryJanoshik Analytical
TestedMarch 2026
MethodHPLC + mass spectrometry
Size5 mg, freeze-dried powder
Stored atKeep it cold and out of the light
Reported resultsas reported by the laboratory
HPLC purity
98.9%
Identity
Confirmed
Measured content
label 5 mg5.08 mg
10 mgLot 2255-80598.85%10.05 mgOpen
98.85%HPLC purity
Lot 2255-805
LaboratoryJanoshik Analytical
TestedMay 2026
MethodHPLC + mass spectrometry
Size10 mg, freeze-dried powder
Stored atKeep it cold and out of the light
Reported resultsas reported by the laboratory
HPLC purity
98.85%
Identity
Confirmed
Measured content
label 10 mg10.05 mg
2 mgLot 2222-23299.52%2.02 mgOpen
99.52%HPLC purity
Lot 2222-232
LaboratoryJanoshik Analytical
TestedJune 2026
MethodHPLC + mass spectrometry
Size2 mg, freeze-dried powder
Stored atKeep it cold and out of the light
Reported resultsas reported by the laboratory
HPLC purity
99.52%
Identity
Confirmed
Measured content
label 2 mg2.02 mg

See the lab results page

What's in a vial of Tesamorelin?

The chemistry, exactly as released.

Identity
SequenceStabilized 44-residue GHRH analog
Molecular formulaC221H366N72O67S
CAS number218949-48-5
Molar mass5135.83 g/mol
Handling
FormatFreeze-dried powder
StorageKeep it cold and out of the light
ReconstitutionBacteriostatic water
Work out the drawPeptide calculatorLab results3 lots, one per size

Who studies Tesamorelin?

Who tends to order this one, and why.

  1. 1

    HIV medicine

    The only indication with pivotal trial evidence, and the population both phase 3 trials enrolled from.

  2. 2

    Endocrinology

    GHRH receptor pharmacology, pulsatile GH release, and the IGF-1 and glucose consequences of raising the axis.

  3. 3

    Body composition research

    Visceral adipose tissue by CT scan is the endpoint, which is a different and more specific measurement than body weight or BMI.

  4. 4

    Anti-doping laboratories

    Tesamorelin is named individually in section S2.2 of the WADA 2026 Prohibited List among growth hormone releasing factors.

Sold for laboratory research only. This is not guidance for personal use, and nothing here is a recommendation.

Where did Tesamorelin come from?

How it got here.

A specific era of HIV therapy created a specific problem, and for a while there was nothing approved for it.

That is a genuinely unusual position for a drug developer to be in. A defined patient group, a defined problem, and an open field.

Theratechnologies, out of Montreal, built for exactly that. Not a repurposing, not a fishing expedition. A programme aimed at one target.

And it worked, in the sense that matters least to marketing and most to science. It got through.

FDA approval landed in 2010, which makes it one of a very small number of peptide drugs to complete the whole route.

Everything else on this shelf is either older than the regulatory era, or never finished. This one finished.

  1. 1

    A defined problem

    A specific era of antiretroviral therapy produced a specific and well-characterised clinical problem, with nothing approved to address it.

  2. 2

    Built in Montreal

    Theratechnologies developed the compound for exactly that indication. Not a repurposing and not a fishing expedition, but a programme aimed at one target.

  3. 3

    Stabilised GHRH

    Native GHRH is cleared by DPP-4 within minutes. A stabilising group on the N-terminus is what makes a 44-residue analogue usable as a medicine.

  4. 4

    Where it stands

    FDA approved in 2010, which makes it one of a very small number of peptide drugs to complete a full development programme through to approval.

How do I buy Tesamorelin in Canada?

What ships, how fast, and the paperwork.

Same day out of British Columbia. Our building, our cold packs, our people, and nothing sitting in a customs queue while you refresh a tracking page.

Then into the fridge. Keep it cold and keep it dark. Sealed and freeze-dried it handles a rough trip without ice. Once it lands, fridge.

Weight neutral, per the label. The FDA-approved label states it is not indicated for weight loss management as it has a weight neutral effect. It moves visceral fat. It does not reduce body weight. That is the manufacturer own wording and it is worth knowing before you buy.

What else do people ask?

5 answers, none of them dodges.

What does the FDA label say it is not for?

No, and the approved label says so explicitly. Under Limitations of Use it states it is not indicated for weight loss management as it has a weight neutral effect. What the trials measured was visceral adipose tissue by CT scan, which fell 14 to 18 percent, while body weight did not meaningfully change.

Is tesamorelin approved in Canada?

Not any more. The 1 milligram product was approved and marketed here from June 2015 and its status changed to cancelled post market on 30 September 2022. The 2 milligram version was cancelled pre-market in July 2023 without ever being marketed. There is no marketed tesamorelin product in Canada today. The cancellation code is sponsor-initiated and does not by itself indicate a safety withdrawal.

What happens if you stop taking it?

The visceral fat comes back. Both phase 3 trials re-randomised patients for a further 26 weeks. Those switched to placebo regained roughly 22 percent in the first study and 16 percent in the second. The effect is entirely dependent on continued dosing.

Why was it never approved in Europe?

The application was withdrawn rather than rejected. Ferrer Internacional withdrew the marketing authorisation application on 26 June 2012, and the withdrawal letter states the CHMP considered that the data provided did not allow it to conclude on a positive benefit-risk balance.

What are the metabolic risks?

GHRH analogues raise growth hormone and therefore IGF-1, and that can worsen glucose tolerance. In the trials, HbA1c of 6.5 percent or higher occurred in 5 percent of tesamorelin patients against 1 percent on placebo, a hazard ratio of 3.3. The label mandates IGF-1 monitoring and states that long-term cardiovascular safety has not been established.

What pairs well with Tesamorelin?

What researchers stack alongside it.

Pairing is where research gets ahead of itself. These are the compounds researchers put in the same order as Tesamorelin Peptide, which is a statement about ordering habits, not about evidence. Two things in one cart have not been studied together unless somebody studied them together.

PerformanceCJC-1295 Ipamorelin Peptide Blend

Two taps on one tub. One copies the brain's growth hormone signal, the other knocks on a second door, and the forums call the pair CJC Ipa.

1
In stock · ships same-day with ice pack
PerformanceCJC-1295 no DAC Peptide

Modified GRF 1-29: the same growth hormone signal without the albumin hook. It clears in minutes instead of days, and that's the whole difference.

1
In stock · ships same-day with ice pack

Supplies for the lab

SuppliesBacteriostatic Water

The water every freeze-dried vial needs, and the one item everybody forgets. Sterile water with a preservative, so one vial lasts more than one draw.

1
In stock · ships same-day with ice pack

What else is in Metabolic?

Other compounds in the same research category.

See all 12 in Metabolic →

Ready to order Tesamorelin?

One last look before you decide.

Freeze-dried, lab results on the page, ships cold

You've got the file and the lab's numbers that back it, lot by lot. If that's the kind of source you were after, Tesamorelin is right here.

For research use only

Sold for laboratory research use only. Not for human or veterinary use, and not for human consumption. 19+. Not approved by Health Canada or any other regulatory body.

Page last updated October 13, 2026. Reviewed by the Pro Peptide team.

What do people search for with Tesamorelin?

Related searches.